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Study of Human Lactation for Effects of
Environmental Contaminants: The North
Carolina Breast Milk and Formula Project
and Some Other Ideas
by Walter J. Rogan* and Beth C. Gladen*
The presence ofenvironmental contaminant chemicals in human milk, their demonstrated toxicity, and
the lackofdata in human beings ledtothe North CarolinaBreast Milkand Formulaproject, athree-center
prospective birth cohort study of856 children. In this study, we measure polychlorinated biphenyls (PCBs)
and DDE in milk and other fluids, follow the course of lactation, and note growth, morbidity and
development in the children. Lactation is hormonally complicated and has parts that are plausibly
interfered with by contaminant chemicals, and certain kinds ofmorbidity that occur in breastfed children
might also represent the result ofchemical contamination ofmilk. Preliminary data analysis confirms the
widespread presence ofchemicals in milk; women with higher DDE levels do not breast-feed as long, but
this is not true for women with higherPCBs. Besides thisstudy, several case-control or survey-type studies,
such as studies of failure to thrive, certain rashes, or short-term breast-feeding would be helpful.
Laboratory studies of enzyme induction are now feasible in children and might be a very sensitive if not
totally specific endpoint for study of PCBs in milk.
Introduction
The widespread occurrence of environmental chemi-
cal contaminants or drugs in human milk is the subject
ofseveral recent reviews (1-4), as well as a topic in this
symposium; for our purposes, we will accept it as given.
The toxicity of the chemicals present in milk is also
detailed here and inthe literature (5); we will notreview
it further. The topics here will be, then, given universal
prevalence of low-level chemical contamination of milk
and nonspecific toxicity of the contaminants, how can
toxicity best be studied in humans? Tb answer this, we
analyze the physiology of lactation to identify disrup-
table parts, and we examine the clinical course of
nursed children to identify vulnerable points ormorbid-
ity that might be attributable to the chemicals in
question. Since we are involved with a large clinical
study in which we measure polychlorinated biphenyls
(PCBs)and2,2-bis(4-chlorophenyl)-1, 1-dichloroethylene
(DDE) in milk and gather morbidity data, we will
discuss these questions in the context ofthe design and
conduct of that study, as well as present some prelimi-
nary results from it. There are other questions that our
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study does not address, and we will mention some of
those. Finally, we will consider some of the estrogenic
properties ofPCBs and DDE; estrogenicity is amecha-
nism by which some of our findings can be plausibly
interpreted.
Endocrinology of Lactation
The initiation of lactation in humans is tied to the
hormonal events at the termination of pregnancy;
however, the anatomic and secretory stage is set at
puberty. In contrast to rodents, humans do not require
the full hormonal expression of pregnancy for full
lactation, since lactation has been reported after deliv-
ery at 4 months or abortion at 3 months. However,
during normal pregnancy, the ductules, lobules (secre-
tory units) and alveoli (collecting units) hypertrophy,
and new lobules are formed under the influence of
estradiol and progesterone, and probably also adrenal
corticosteroids. Differentiation of the alveolar lining
cells begins at the end of the first trimester, and a
secretoryhistologyispresentfromthefourthmonth on.
Estrogens alone can cause hypertrophyinbreasttissue;
theyactsynergistically withprolactinduringpregnancy
(6). Prolactin concentrations begin to rise very early inROGAN AND GLADEN
pregnancy, before milk secretion can be established.
They remain high for the first few days or weeks
postpartum whether or not breast-feeding is done.
Prolactin is essential for initiation of lactation; women
treated with bromocriptine (which selectively inhibits
the secretion of prolactin) or who have Sheehan's
syndrome (hypopituitarism from postpartumnecrosis of
thepituitary) do notlactate. Afterthethird postpartum
week, prolactin concentrations vary and seem to be
related to suckling stimulation. The highconcentrations
present at term are not maintained (7).
The veryhighconcentrationsofestrogensand proges-
terone that support pregnancy fall precipitously at
term, and this disappearance correlates with the begin-
ning of lactation. Given postpartum, estrogens such as
diethylstilbesterol (DES) or estradiol inhibit lactation
but do not alterprolactin secretion. Itthus appears that
estrogens are peripherallactation inhibitors, even when
the breast is stimulated by prolactin. This may be the
mechanism seen in the more subtle effect ofcontracep-
tive estrogens, which decrease the duration oflactation
(8). Lactation is a time of relative estrogen deficiency.
Postpartum amenorrhea is more prolonged in breast-
feeders (9).
Prolactin stimulates milkproduction. Oxytocin stimu-
latesmilkejection. Itissecretedin responsetosuckling,
although concentrations are very low and hard to
measure. The letdown, or milk ejection reflex, is
probably oxytocin-mediated. Letdown does not require
actual contact with the infant in humans or animals; the
sight of an infant, or the sound of its cry can elicit the
response. Presumably, some oftheimpactofpsychologi-
cal or emotional disturbance on breast-feeding is medi-
ated through interference with this response. Oxytocin
is essential for milk ejection in humans, but not in all
animals. In rats, the oxytocin-induced milk ejection
reflex is decreased by estrogen (7).
Introductionoffoodsotherthanbreastmilk(weaning)
is presumably accompanied by less efficient emptyingof
the breasts. Although there is storage space for per-
haps 48 hr ofproduction, distention ofthe alveolar sacs
results indecreased milksynthesis. Involution ofbreast
tissue is apparently governed predominantly by local
factors, and what role hormones play is not clear (7).
Prolactin appears to inhibit luteotropin-releasing hor-
mone, and thus the release ofluteinizing hormone and
follicle-stimulatinghormone, andabouthalfofall women
do not menstruate until they have weaned completely
(6). At some point, however, menses return. Some
women lactate through several ovulations; indeed,
women in our study occasionally report that the reason
thattheyweaned one child was thatthey were pregnant
with another. Serial pregnancies have been reported
with uninterrupted lactation (10).
Clinical Characteristics of
Breast-Fed Children
The percentage ofmothers who try to breast-feed at
least partially is increasing. Formula manufacturers
periodically attempt counts. Annual surveys done by
Ross Laboratories from 1955 through 1979 show that in
1970, 25% ofchildren were breast-fed completely at one
week and 6% were still getting some breast milk at 6
months; for 1979, the figures were 50% and 23% (11).
Although young, white, college-educated women are
most likely to breast-feed, there have been increases in
all age and race groups in these data. The degree of
encouragement offered to a mother to breast-feed and
the enthusiasm and expertise that back it up are quite
variable; there is some evidence that successful breast-
feeding is aided by knowledgeable social support (12).
Thereisconsensusthatthegoalofmedicalrecommen-
dations is to increase breast-feeding (13). Most recom-
mendations made by and to organizations concerned
with infant nutrition, such as the American Academy of
Pediatrics (14) and the World Health Organization (15),
are for breast milk for everyone. There is general
agreement that a child can be totally breast-fed for the
first 6 months oflife by a healthy mother; supplemental
vitamins K and D (16) in the newborn period and iron
are generally recommended. Some babies breast-feed
for a year or so, are weaned directly to a cup, and seem
to do fine. The empirical basis forthe recommendations
is variable and depends strongly on whether developing
or developed countries are under discussion. In the
Third World, there are situations where there is neither
money to buy adequate supplies of formula nor clean
water with which to prepare it, and where there is
substantial infant mortality from diarrheal diseases
against which breast-feeding offers defense. The mar-
keting of formula in the third world is a matter of
intense controversy (17-19). Inthe United States, there
is evidence that children have lower risks of lower
respiratory tract infections (20) and hospitalizations for
gastroenteritis (21) while being breast-fed. There is
mixed evidence about the frequency of allergies in
breast-fed children with astrongfamily history ofatopy
(22). There is much laboratory evidence concerning the
presence in milk of IgA, white cells, and other sub-
stances that ought to be beneficial (23). In addition,
there are appeals to ease and convenience, resistance to
spoilage, and Darwinian biology.
There are some unresolved issues. Not all women
seem to be able to breast-feed satisfactorily, as judged
either by a reasonably steep growth curve or a reason-
ably silent, happy child. Such troubles, termed "failure
to thrive at the breast" (24,25), can occur despite
adequate nutrition, motivation, and support. Breast-fed
children are lighter than bottle-fed children, and they
become more so the longer they are breast-fed (26).
From a simple calorie intake point of view, this is not
surprising. Milk production in most women does not
exceed about 800 mL/day, although there are a few
exceptions (27). Thus the calories to supportmore rapid
growth are simply not there (28). This observation has
caused some controversy; the argument has been made
that the growth ofthe totally breast-fed child is optimal
in some sense (29-31), and that this more appropriate
early growth rate is protective against later obesity, the
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most common nutritional disorder in developed coun-
tries. There is no empirical support for this claim.
Some women secrete in their milk a pregnanediol
which is absorbed by the child and which inhibits
glucoronization of bilirubin (32). At about the fourth
week of life, such children develop bilirubins of two to
three times normal, which decline if breast-feeding is
stopped (33,34). It is claimed that such children can be
put back on the breast after several days and that the
condition will not recur (35). Some breast-fed children
have prolonged physiologic jaundice in the neonatal
period; it is sometimes the practice to supplement with
water or wean them. It is not clear that such prolonga-
tion occurs more frequently in breast-fed than in
bottle-fed children, nor is there evidence for the effec-
tiveness of supplementation (34,35). Finally, there are
animal models in which vertical transmission of virus
associated with mouse mammary tumors occurs from
mother to daughter through milk; the offspring then
have higher rates of mammary tumors. This is a very
difficult issue to study epidemiologically, but the evi-
dence seems to be that human breast cancer is not
virus-induced, andthat, while daughters ofwomen with
breast cancer do have ahigherrate, it is independent of
whether or not they were breast-fed (36).
Studying Breast-Feeding for Effects
of Pollutants in Milk
Breast-feeding is thus subject to a complex interplay
of hormonal, social, medical and other forces, and its
normal course might plausibly be interfered with by
some deleterious substance either through an effect on
the mother or on the child. Given the all but universal
contamination of milk and the demonstrated biological
activity of the chemicals in question, the notion of
toxicity cannot be ruled out. Any calculation ofdose to
the breast-fed child yields daily consumptions that
regularly exceed Allowable Daily Intake guidelines (2),
and in fact overlap the doses at which toxicity like
enzyme induction can be shown to occur in the labora-
tory (37). Nevertheless, thereis substantial observation
ofthe clinical course ofbreast-fed children in developed
countries, and they do not as a rule develop chloracne,
fail to grow, appear to be immunodeficient, or handle
drugs in an observably inferior way to bottle-fed
children. When we designed the current study, then,
oursuspicion wasthatreadilyseentoxicitywasunlikely,
and thus that any study was likely to be negative.
However, apersuasivelynegative studywouldbeuseful,
giventhe suspicions raised on toxicological grounds and
the prevalence and magnitude of contamination.
The straightforward way to study the effects of
contaminated breast milk is to identify a cohort, docu-
ment its exposure, and follow it over time, noting
illnesses, growth, development, or any other phenom-
ena asthey occur. While straightforward, this approach
has obvious disadvantages. It takes a long time, it has
lowpowerto detect associations between exposures and
rare events unlessthe associations are verylarge, andit
is expensive in both dollars and investigator time. We
thus thought about several design alternatives that are
quicker, cheaper or both.
A quicker method is to study breast-fed children and
bottle-fed children retrospectively. The assumption be-
hind such a design is that all breast-fed children are
exposed to contamination and bottle-fed children are
not. We could decide what criteriawere necessary to be
called breast-fed, say, no more than one bottle per day
to 6 weeks with some breast-feeding to 6 months, and
have the bottle-fed group be totally bottle-fed. We
would then pick an age, say, 6 months, at which cases
and controls would be identified, and look retrospec-
tively at weight gain, frequency of infection, birth
weight, etc. The problem with this kind ofstudy is that
it is biased in favor of breast-feeding (38), but to an
unmeasurable degree. Children who remain breast-fed
to 6 months represent a subset of the children who
started, andtheyaremostlythe oneswhohavedonethe
best. Children who become ill or fail to gain weight
while being breast-fed are usually supplemented or
weaned. Such children would not appearin eithergroup
in a study like this, yet it is among them that much of
the total morbidity is occurring. Such a study would
thus be likely to show no effect of contaminated milk,
but could not be persuasive, however large it was.
Another quicker possibility was cross-sectional or
survey designs. Children of various ages could be
identified; various aspects of their health could be
studied, their method of feeding could be determined,
and their mother's milk could be tested. Unfortunately,
theresultsofsuchtestingwouldbedifficulttointerpret.
Women start with a certain concentration of chemicals
in their milk, but over the course of lactation, some of
the chemicals will be transferred to their child. Thus
the measured concentration ofchemicals would depend
onthe age ofthe child and the amount ofbreast-feeding
that was done, as well as the woman's initial concen-
tration. It would be difficult to determine whether the
child of a woman with a low current concentration had
always been exposed to a low concentration or had
previously been exposed to a high one.
Often in epidemiological work, the fastest and most
powerful technique is a case-control study. In such a
design, some illness is picked, such as acneform rash,
failure to thrive, or frequent infections, and contami-
nated breast milk is sought as a risk factor. Because of
its retrospective nature, such a design would suffer
fromthe same difficulties mentioned above. In addition,
no single illness is under suspicion, so taking such an
approach would involve a series of studies of different
illnesses; alternately, we would need to know ahead of
time what illness or condition was most sensitive to the
chemicals. Ineithercase, such adesign would still leave
open questions about unstudied illnesses.
Before facingthe necessity ofa live cohort study, one
option remained; perhaps a paper cohort, rather than a
real one, could be followed. In these kinds of studies,
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records routinely generated for clinical or other pur-
poses are examined, rather than the actual patients.
Such studies are laudable in their simplicity, and when
it happens that the information that has been gathered
is the information you want, they can be quite efficient
and timely. We could not find, however, any group of
children on whom records had been kept and from
whom breast milk samples had been collected in such a
way that we could go back and analyze them.
The North Carolina Project: Design
This exhausted our alternate studies, so we set about
the design ofa longitudinal study. The basic question to
be answered was of a dose-response nature. We there-
fore neededtolookatdoseandsomeofitsdeterminants,
identify and document the most plausible responses,
and get information on other factors that might con-
found the relationship between the two.
All children are exposed transplacentally. The addi-
tional dose to the breast-fed child is a combination of
concentration of contaminant chemicals, volume per
unit time, and duration ofbreast-feeding. Measurement
of the first presented technical problems, ultimately
solved by our chemists (39). Since we were going to the
trouble of analyzing breast milk, we also collected and
analyzed samples ofmaternal and cord blood, placenta
and some formula. Determinants ofmaternal concentra-
tion are things like diet of the mother, occupation,
cigarette and alcohol use, weight, age and some demo-
graphic characteristics. Volume of breast milk con-
sumed is a problem, since the only reliable way to
measure it is individual test weighings before and after
all feedings. This was not logistically possible, and we
have had to make an assumption that the variation in
the amount of milk consumed per day does not over-
whelm the variation in contaminant concentration.
Duration is not a totally clean endpoint, in that women
vary a great deal in their weaning practices and do not
abruptly stop complete breast-feeding and go to other
foods.
Proposed response measures were more difficult.
From animal studies and human data, we constructed
a list of possible outcomes. Effects at birth due to
transplacental exposure were low birth weight, hyper-
bilirubinemia, hepatosplenomegaly, acne,pigmentation,
natal teeth, and perhaps some delay in central nervous
system development. Later effects would be similar;
they include poor weight gain, increased frequency of
infection, certainrashes orpigmentation, hepatospleno-
megaly, and delay in central nervous system develop-
ment. All of these might show up as a tendency for
mothers to breast-feed forshorterlengths oftime. Most
of this information is of the kind gathered routinely
during well-child care and can be obtained by a simple
physical examination of the child, a medical history of
the child supplied by the mother, and a review of
medical records for confirmation ofillnesses. We made
up a standard physical, with some special attention to
liver and spleen size and rashes. Besides a regular
medical history, we were interested in breast-feeding
success and duration. In order to reduce the biases in
comparisons between breast-fed and bottle-fed groups,
we wanted to be able to separate out children who had
switched to the bottle because they had not been doing
well at the breast. Thus we had several questions on
when weaning had begun and ended, and why. In
addition to our own history, we also made up a standard
form for review of the child's medical record.
Measurement of effects on the central nervous sys-
tem is difficult, however. For use in newborns, there
were two reasonably standardized scales: the Prechtl
neurological exam (40) and the Brazelton Neonatal
Behavioral Assessment Scale (41). The Prechtl exam,
although extremely detailed and rigorous, required a
physician, preferably apediatrician, and preferably one
who had trained with Prechtl in its use. The Brazelton
was in use by nurses and physical therapists, had been
used under a variety ofconditions forresearch, and had
good reliability. It was sensitive to prematurity, to
drugs like anesthetics given intrapartum, and to the
withdrawal state in children of mothers addicted to
narcotics. Therewas, however, not sufficient experience
with it to be confident about its ability to predict later
dysfunction, except perhaps at extremes. It was time-
consuming to administer and did not produce a single
number, but rather scores on a series of scales. We
chose to use the Brazelton. For children from 6 months
to 2 years, the only serious candidate instrument was
the BayleyScales ofInfant Development(42), which has
wide acceptance as aresearchtooland withwhichthere
isexperience andfamiliarity. Itgeneratestwonumbers,
a motor and a mental developmental index. Children
graduate from the Bayley at age three; one canthen use
one of several standard IQ tests. However, experience
had begun to accrue with the McCarthy Scales of
Children's Abilities (43), aschoolreadiness testwith six
scales relating to both mental and motor abilities,
which seemed to be relatively free of strong cultural
influence. These scales did not have the standardization
data available that the IQ tests had, but we were
persuaded by their other features to use them.
Initially, we set our period of follow-up as 6 months,
because it was our beliefthat almost all breast-feeding
would be during that time, and because we were
originally only concerned about short-term effects. As
it turned out, among the women whom we followed,
breast-feeding often extended well beyond 6 months, at
least to the extent ofa nursing morning and night. We
eventually decided to extend the study to 5 years.
Another necessary decision was sample size. We were
interested in multiple outcomes and had a group whose
exposures were changing over time, so we could not
calculate a single number that would give us a specified
power to detect important associations and declare
them statistically significant. We tried to decide what
comparisons would be the most difficult to make and to
ensure that we would have enough children available for
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them, although it turned out later that our guesses
about the breast-feeding practices and contaminant
levels ofthese women were not very good. The sample
sizes we got from this exercise were then decreased
rather substantially to accord with the practical con-
straints ofthe number ofbirths availableinthe areaand
the percentage of women who could be induced to
volunteer for this rather time-consuming study. We
finally decided that about 300 women each from three
centers would be a reasonable goal.
The first baby enrolled in the study was born in April
1978, and the 856th and final one in October 1982. We
recruited volunteers from three sources in North
Carolina: The Durham Women's Clinic, a large subur-
ban group practice, the Wake County Area Health
Education Center, a university-affiliated group provid-
ing medical faculty and other services to the Wake
County Hospital in Raleigh, and the Department of
Pediatrics of the East Carolina University School of
Medicine in Greenville. Families were found through
hospital tour presentations, through Lamaze and pre-
pared childbirth classes, and to some extent by word of
mouth. At or near term, mothers gave written consent
and were given a questionnaire. During the admission
forlaborand delivery, we collected maternal blood, cord
blood, placenta, and a sample ofwhatever the child was
eating (colostrum/early milk or formula). We examined
the child, performed the Brazelton, and reviewed the
obstetric and nursery record. We saw the child again at
6 weeks, did a physical, obtained the child's medical
history, and collected blood and breast milk or formula.
There was asimilar visit at 3 months, except that we no
longer collected maternal blood. At 6 months, the
Bayley scales were done, and a new consent for further
follow-up was signed. There are visits at 1 year, 18
months, 2 years, and then yearly; they consist of a
historyandphysical, medical andhospitalrecordreview,
and Bayley or McCarthy scales. Breast milk is collected
as long as the mother is lactating. The final visit is at 5
years of age. We are now converting to a registry for
follow-up, and will keep a current file of names and
addresses through a yearly mail or phone contact.
The North Carolina Project:
Preliminary Findings
We have extended or confirmed a variety offindings
from these data, as well as making some new observa-
tions. The expected, almost universal, contamination of
milkby PCBs and DDE was confirmed. Ournumbers in
North Carolina appear to be somewhat higher than
national (2) orMichigan (44) numbers forPCBs. We find
norelationship between age, race, reported occupation,
or cigarette smoking and PCBs; regular alcohol use is
associated with somewhat higher levels. DDE goes up
withage and is higherin blacks and smokers. Values for
both chemicals decline over the course of lactation; on
the average, values at 6 months are about 20% lower
than in the beginning of lactation. Both chemicals are
about 3-fold higher in maternal term blood than in cord
blood. We were unable to confirm an association be-
tweenthese chemicals and prematurity (45,46); forboth
chemicals, the correlation with birth weight is essen-
tiallyzero. Thisis notbecause ourstudyistoo small; we
were able to show readily the familiar 200-g decrement
in birth weight associated with smoking. Mothers
whose children are jaundiced or who are treated for
jaundice do not have higher levels, and overall stay in
the hospital is the same across all levels.
Women with higher levels of DDE tend not to
breast-feed as long; those in the top 5% for DDE have a
median duration of breast-feeding of 9 weeks, while
those in the bottom 6% breast-feed 35 weeks. This
relationship is not an artifact ofage, since older women
tend to breast-feed longer in spite oftheir higher DDE
levels. Neither is it due to parity or race; we restricted
the analysis to whites, and the same result holds for
first-borns only. Socioeconomic status is difficult to
measure in this group offamilies, but we appearto have
little variability. Women with higher levels report more
often an early weaning for reasons like "not enough
milk" or "difficulty feeding"; thus it does not appear
that the relationship is an artifact due to women who
must leave the home having higher levels. The concen-
tration of PCBs does not appear to be related to
duration of breast-feeding.
Reduction in the length oftime spent breast-feeding
is consistent either with an effect on the child or on the
mother. Ifmilk with higher levels ofcontaminants fails
to provide a full measure of immunologic protection or
basic nutrition, the children would tend not do as well
and thus be supplemented or weaned earlier. Basically
this is the mechanism we proposed might operate when
we designed the study, and we are now looking at
illnesses, weight gain, and development. However, in
the children exposed to the higher levels of contamina-
tion, lactation time tends to be short, so it is not clear
that we will be able to see such an effect even if it is
present.
A maternal effect is an alternative explanation. One
possibility is that it is mediated through an estrogenic
effect. Certain PCB congeners are estrogenic, as is
o,p-DDE. Although they are very weak on a mole-to-
mole basis compared with estradiol or DES, they are
persistent (47) and thus might interact with estrogen
receptors over a long period of time and lead to the
expression of an effect at low doses. There are no
directly applicable laboratory data on this question.
However, kepone, a compound that shares some struc-
ture with PCBs and DDE, can be shown to be an active
estrogen in a mouse system at very low doses if the
duration ofexposure is long and the chemical is allowed
to accumulate (48). In addition, the administration of
certain PCB mixtures in rats induces altered liver
metabolism of estrogens and can result in a uterine
weight response that is different from controls. We are
currently discussing the feasibility of an animal model
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in which duration of lactation as measured endocrino-
logically and histopathologically is used as an endpoint.
There are no studies in which this phenomenon has
been examined in detail in common laboratory species,
such as the mouse or the rat, as a toxicological
endpoint. The substantial literature on lactation in
dairy animals is related mostly to endocrine responses.
Other Ideas
Various conditions of unknown etiology which might
be related to these chemicals have been described in
children. While none ofthem are totally plausible as the
assured outcome of contaminated milk, the measure-
ment of contaminants might be done in the context of
another etiologic study. One such condition is late-
occurring breast-milk jaundice. Although incidence
figures are hard to get, the condition is too rare for a
study like ours to have many cases. As mentioned
above, the physiologic mechanism of unconjugated
hyperbilirubinemia at 3 to 12 weeks is thought to be the
presence of a pregnanediol that inhibits glucuronyl-
transferase. However, only about 70% of the children
with this condition have appreciable amounts of hor-
mone in their milk, and thus a reasonable study might
involve either looking at the milks ofthose who did not
have the hormone or looking at all cases for an interac-
tion with the hormone.
Several skin diseases might represent cases ofchemi-
cal toxicity. The pigmented spots noted by Harlap (49)
or neonatal pustular melanosis (50) might be a mild
form ofthe neonatal chloracne seen in Yusho. Inneither
of these conditions is the frequency of breast-feeding
noted in the reports describing the cases, and thus a
necessary first step would be the establishment ofthat
relationship. Eczema, on the other hand, has now been
reported in several different studiestobemore frequent
among breast-fed children (22), and the suggestion has
been made that this may represent the effect of
contaminant chemicals. Eczema has not been shown to
be associated with these chemicals in outbreaks of
illness, but it would be easy to study and has some
plausibility.
Finally among these sorts of studies, the issue of
failure to thrive at the breast might be studied in
case-control fashion, to see whether women who report
this condition are at an extreme. Based on animal
studies, this is quite a plausible outcome of several of
the chemicals in question, most notably PCBs.
Given that one has access to a large number of
children on whom milk analyses have been done, a
variety ofstudies are possible in which one can compare
those with the highest and lowest exposures. At the
moment, the most sensitive ofthe feasible studiesbased
on laboratory work is the caffeine breath test (51,52).
Caffeine-o-demethylase is a P-448 enzyme that is read-
ily induced by environmentally occurring polycyclic
hydrocarbons; it is most strongly induced by methyl-
cholanthrene, but it is also induced by PCBs. The test
measuresthemetabolismofcaffeinebycountingradiola-
beled CO2 in expired air. The amount of radiation
exposure is small, the test is reproducible, and it has
been shown to be sensitive to cigarette smoking.
Antipyrine clearance has been shown to be altered in
adults who work around PCBs (53), but antipyrine
clearance studies require serial blood measurements
and are really best done on an inpatient basis. The
breath test should be suitable for use in outpatient
children.
Discussion
We think that lactation offers a variety ofopportuni-
ties to investigate either exposure to environmental
chemicals or their toxicity in a group that might be
among the most susceptible ofhumans because oftheir
rapid growth, immaturity of metabolism, and limited
diets. There are few groups now working in the area
because the studies are difficult. Participation is time-
consuming and tedious forthe mother, and the chemical
analytic procedures are expensive, cumbersome and
subject to contamination. However, as more focused
ideas are studied and as laboratory measures improve,
perhaps bythe field applicability ofaradioimmunoassay
for PCB, the sparse literature should grow and the
nonspecific anxieties generated by reports ofpollutants
in milk should be replaced by realistic consideration of
plausible toxicity based on good data.
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